Literature DB >> 2590161

Defective activity of acyl-CoA:cholesterol O-acyltransferase in Niemann-Pick type C and type D fibroblasts.

D M Byers1, S R Rastogi, H W Cook, F B Palmer, M W Spence.   

Abstract

The activity of acyl-CoA:cholesterol acyltransferase (ACAT; EC 2.3.1.26) was measured in fibroblast homogenates from Niemann-Pick Type C (NPC) and Type D (NPD) patients to determine whether these cells exhibit similar defects in the regulation of cholesterol esterification. ACAT activity in normal cells cultured in the absence of serum lipoproteins responded rapidly (within 6 h) to the addition of serum and reached peak levels at 12-24 h, whereas little stimulation of activity in NPC cells was observed. In contrast, ACAT activity in NPD fibroblasts (cell lines from four different patients) began to increase between 6 and 12 h after serum addition, reaching levels up to 50% of normal values at 24 h. ACAT activity in NPC and NPD cell extracts could not be stimulated by preincubation with normal cell homogenates, nor was complementation between NPC and NPD homogenates observed. Addition of 25-hydroxycholesterol to fibroblasts cultured in delipidated serum increased ACAT activity for all three cell types, although stimulation in NPD cells was less than that observed in NPC cells. ACAT activity of deoxycholate-solubilized homogenates reconstituted into phosphatidylcholine vesicles was independent of the presence of serum lipoproteins during culture and dependent on cholesterol present in the vesicles for all cell types. However, ACAT activities of mutant fibroblasts in vesicles plus cholesterol were significantly (about 40%) lower than control levels. These results suggest that the metabolic lesions in NPC and NPD cells are biochemically distinct and that both may involve factors in addition to the availability of cholesterol substrate for the ACAT enzyme.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2590161      PMCID: PMC1133333          DOI: 10.1042/bj2620713

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

Review 2.  The low-density lipoprotein pathway and its relation to atherosclerosis.

Authors:  J L Goldstein; M S Brown
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

3.  Cholesterol acyltransferase.

Authors:  J T Billheimer
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

Review 4.  Role of acyl-CoA: cholesterol acyltransferase in cellular cholesterol metabolism.

Authors:  K E Suckling; E F Stange
Journal:  J Lipid Res       Date:  1985-06       Impact factor: 5.922

5.  Evidence for phosphorylation/dephosphorylation of rat liver acyl-CoA:cholesterol acyltransferase.

Authors:  K L Gavey; D L Trujillo; T J Scallen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

6.  Dual modulation of hepatic and intestinal acyl-CoA: cholesterol acyltransferase activity by (de-)phosphorylation and substrate supply in vitro.

Authors:  K E Suckling; E F Stange; J M Dietschy
Journal:  FEBS Lett       Date:  1983-01-10       Impact factor: 4.124

7.  The effects of low-density lipoprotein and cholesterol on acyl-coenzyme A: cholesterol acyltransferase activity in membranes from cultured human fibroblasts.

Authors:  S J Gavigan; B L Knight
Journal:  Biochem J       Date:  1983-10-15       Impact factor: 3.857

8.  A defect in cholesterol esterification in Niemann-Pick disease (type C) patients.

Authors:  P G Pentchev; M E Comly; H S Kruth; M T Vanier; D A Wenger; S Patel; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

9.  Regulation of acyl CoA:cholesterol acyltransferase by 25-hydroxycholesterol in rabbit intestinal microsomes and absorptive cells.

Authors:  F J Field; S N Mathur
Journal:  J Lipid Res       Date:  1983-08       Impact factor: 5.922

10.  Esterification of cholesterol and 25-hydroxycholesterol by rat liver microsomes.

Authors:  A H Lichtenstein; P Brecher
Journal:  Biochim Biophys Acta       Date:  1983-05-16
View more
  5 in total

1.  Niemann-Pick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop.

Authors:  G Millat; C Marçais; C Tomasetto; K Chikh; A H Fensom; K Harzer; D A Wenger; K Ohno; M T Vanier
Journal:  Am J Hum Genet       Date:  2001-05-01       Impact factor: 11.025

2.  Linkage of Niemann-Pick disease type D to the same region of human chromosome 18 as Niemann-Pick disease type C.

Authors:  W L Greer; D C Riddell; D M Byers; J P Welch; G S Girouard; S M Sparrow; T L Gillan; P E Neumann
Journal:  Am J Hum Genet       Date:  1997-07       Impact factor: 11.025

3.  The Nova Scotia (type D) form of Niemann-Pick disease is caused by a G3097-->T transversion in NPC1.

Authors:  W L Greer; D C Riddell; T L Gillan; G S Girouard; S M Sparrow; D M Byers; M J Dobson; P E Neumann
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

Review 4.  Niemann-Pick disease type C: an update.

Authors:  M T Vanier; P Pentchev; C Rodriguez-Lafrasse; R Rousson
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

5.  Adenovirus RIDα uncovers a novel pathway requiring ORP1L for lipid droplet formation independent of NPC1.

Authors:  Nicholas L Cianciola; Diane J Greene; Richard E Morton; Cathleen R Carlin
Journal:  Mol Biol Cell       Date:  2013-09-11       Impact factor: 4.138

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.